amgen glp 1 drug Amgen's obesity may help patients keep the weight off Market Overview: GLP-1 Agonists and
Description
However, tirzepatide differs from the other medications in that it is a dual-action GLP-1 (short for glucagon-like peptide 1) and GIP (short for glucose-dependent insulinotropic polypeptide) medication
[PMC free article] [PubMed] [Google Scholar] 21.Rosenstock J., Nino A., Soffer J., et al
Hall, S., Isaacs, D., and Clements, J.N
Lipid Modulation GLP-1RAs exert favourable effects on lipid profiles, primarily reducing triglycerides and, to a lesser extent, LDL cholesterol
